Journal
BRITISH JOURNAL OF PHARMACOLOGY
Volume 171, Issue 2, Pages 438-451Publisher
WILEY
DOI: 10.1111/bph.12466
Keywords
QX-314; TRPV1; TRPA1; nociception; CAP; sciatic nerve; DRG
Categories
Funding
- NIH [NS072040, NS064274]
- Deutsche Forschungsgemeinschaft [BR 2923/1-1, GE 695]
- LOEWE Lipid Signaling Forschungszentrum Frankfurt (LiFF)
- Else Kroner-Fresenius-Stiftung
- Johannes und Frieda-Marohn-Stiftung
- MICINN/Fulbright programme
- Research Program of the University of Granada
- Endo Pharmaceuticals
Ask authors/readers for more resources
Background and PurposeSelective nociceptor fibre block is achieved by introducing the cell membrane impermeant sodium channel blocker lidocaine N-ethyl bromide (QX-314) through transient receptor potential V1 (TRPV1) channels into nociceptors. We screened local anaesthetics for their capacity to activate TRP channels, and characterized the nerve block obtained by combination with QX-314. Experimental ApproachWe investigated TRP channel activation in dorsal root ganglion (DRG) neurons by calcium imaging and patch-clamp recordings, and cellular QX-314 uptake by MS. To characterize nerve block, compound action potential (CAP) recordings from isolated nerves and behavioural responses were analysed. Key ResultsOf the 12 compounds tested, bupivacaine was the most potent activator of ruthenium red-sensitive calcium entry in DRG neurons and activated heterologously expressed TRPA1 channels. QX-314 permeated through TRPA1 channels and accumulated intracellularly after activation of these channels. Upon sciatic injections, QX-314 markedly prolonged bupivacaine's nociceptive block and also extended (to a lesser degree) its motor block. Bupivacaine's blockade of C-, but not A-fibre, CAPs in sciatic nerves was extended by co-application of QX-314. Surprisingly, however, this action was the same in wild-type, TRPA1-knockout and TRPV1/TRPA1-double knockout mice, suggesting a TRP-channel independent entry pathway. Consistent with this, high doses of bupivacaine promoted a non-selective, cellular uptake of QX-314. Conclusions and ImplicationsBupivacaine, combined with QX-314, produced a long-lasting sensory nerve block. This did not require QX-314 permeation through TRPA1, although bupivacaine activated these channels. Regardless of entry pathway, the greatly extended duration of block produced by QX-314 and bupivacaine may be clinically useful.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available